Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Chi-Cheng Chen, Hsiu-Ling Chen, Pi-Ling Chiang, Sheng-Dean Luo, Yen-Hsiang Chang, Wei-Chih Chen, Cheng-Kang Wang, An-Ni Lin, Yueh-Sheng Chen, Shun-Yu Chi & Wei-Che Lin. (2022) Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study. International Journal of Hyperthermia 39:1, pages 907-917.
Read now
Read now
Articles from other publishers (20)
Paola Monciino, Lorenza Magagnoli, Eliana Fasulo, Michela Frittoli, Chiara Leotta, Hoang Nhat Pham, Andrea Stucchi, Paola Ciceri, Andrea Galassi & Mario Cozzolino. (2022) Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism. Kidney and Dialysis 2:3, pages 482-494.
Crossref
Crossref
Valentina Perrone, Melania Dovizio, Chiara Veronesi, Margherita Andretta, Fausto Bartolini, Arturo Cavaliere, Fulvio Ferrante, Alessandro Lupi, Romina Pagliaro, Rita Pagnotta, Stefano Palcic, Davide Re, Loredana Ubertazzo, Adriano Vercellone & Luca Degli Esposti. (2022) Real-World Evaluation of Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease, in an Italian Clinical Setting. Healthcare 10:4, pages 709.
Crossref
Crossref
Mahmoud F. SakrMahmoud F. Sakr. 2022. Parathyroid Gland Disorders. Parathyroid Gland Disorders
81
147
.
Andre Luis Maion Casarim. 2021. Mineral Deficiencies - Electrolyte Disturbances, Genes, Diet and Disease Interface. Mineral Deficiencies - Electrolyte Disturbances, Genes, Diet and Disease Interface.
Anjay Rastogi, Nisha Bhatt, Sandro Rossetti & Judith Beto. (2021) Management of Hyperphosphatemia in End-Stage Renal Disease: A New Paradigm. Journal of Renal Nutrition 31:1, pages 21-34.
Crossref
Crossref
Josip Lesko, Nikolina Obradović & Vana Turudić. 2021. CMBEBIH 2021. CMBEBIH 2021
609
616
.
Danjun Guo, Hui He & Tao Hou. (2020) Purification and characterization of positive allosteric regulatory peptides of calcium sensing receptor (CaSR) from desalted duck egg white. Food Chemistry 325, pages 126919.
Crossref
Crossref
Takashi Shigematsu, Masafumi Fukagawa, Keitaro Yokoyama, Takashi Akiba, Akifumi Fujii, Atsushi Shinoda & Tadao Akizawa. (2019) Influence of dialysate Ca concentrations on the therapeutic effects of etelcalcetide with concomitant drugs in patients with secondary hyperparathyroidism. Nephrology 25:8, pages 634-643.
Crossref
Crossref
Antonio Bellasi, Mario Cozzolino, Fabio Malberti, Giovanni Cancarini, Ciro Esposito, Carlo Maria Guastoni, Patrizia Ondei, Giuseppe Pontoriero, Ugo Teatini, Giuseppe Vezzoli, Marzia Pasquali, Piergiorgio Messa & Francesco Locatelli. (2019) New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology. Journal of Nephrology 33:2, pages 211-221.
Crossref
Crossref
Giorgina Barbara Piccoli, Tiziana Trabace, Antoine Chatrenet, Carlos Alberto Carranza de La Torre, Lurlinys Gendrot, Louise Nielsen, Antioco Fois, Giulia Santagati, Patrick Saulnier & Nicola Panocchia. (2020) New Intravenous Calcimimetic Agents: New Options, New Problems. An Example on How Clinical, Economical and Ethical Considerations Affect Choice of Treatment. International Journal of Environmental Research and Public Health 17:4, pages 1238.
Crossref
Crossref
Amos Baruch & Derek Maclean. 2019. Successful Drug Discovery. Successful Drug Discovery
131
153
.
Andrea Galassi, Paola Ciceri, Eliana Fasulo, Stefano Carugo, Giuseppe Cianciolo & Mario Cozzolino. (2019) Management of Secondary Hyperparathyroidism in Chronic Kidney Disease: A Focus on the Elderly. Drugs & Aging 36:10, pages 885-895.
Crossref
Crossref
Kazuhiko Tsuruya, Ryutaro Shimazaki, Masafumi Fukagawa, Tadao Akizawa, Yoshimitsu Hayashi, Hidetomo Nakamoto, Shoji Koga, Ichiro Okido, Minoru Kubota, Fumihiko Koiwa, Masahiro Takeda, Terumasa Hayashi, Makoto Hiramatsu, Hideki Kawanishi, Hidetoshi Kanai, Sakuya Ito, Kazuhiko Tsuruya, Koji Mitsuiki & Hirofumi Ikeda. (2019) Efficacy and safety of evocalcet in Japanese peritoneal dialysis patients. Clinical and Experimental Nephrology 23:6, pages 739-748.
Crossref
Crossref
Keitaro Yokoyama, Ryutaro Shimazaki, Masafumi Fukagawa, Tadao Akizawa, Yoshitaka Maeda, Kazue Ueki, Takayuki Fujii, Ryoichi Miyazaki, Hisanori Azekura, Hirotake Kasuga, Yoshiyuki Tomiyoshi, Takeaki Shinzato, Ryuji Iwashita, Kenji Takada, Akio Suda, Takashi Nagaoka, Mitsuru Yoshimoto, Masatomo Taniguchi & Hiroshi Ogawa. (2019) Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis. Scientific Reports 9:1.
Crossref
Crossref
Judith Beto, Nisha Bhatt, Teresa Gerbeling, Chhaya Patel & Debra Drayer. (2019) Overview of the 2017 KDIGO CKD-MBD Update: Practice Implications for Adult Hemodialysis Patients. Journal of Renal Nutrition 29:1, pages 2-15.
Crossref
Crossref
Tasha Ruffin. (2018) Pharmacologic Renal Therapy. Nursing Clinics of North America 53:4, pages 491-497.
Crossref
Crossref
Yogendranath Purrunsing, Jingjing Zhang, Ying Cui, Wei Liu, Yi Xu, Xunning Hong, Changying Xing, Xiaoming Zha & Ningning Wang. (2018) Sixty-Two-Year-Old Male Suffering From Uremic Leontiasis Ossea Caused by Severe Secondary Hyperparathyroidism. JBMR Plus 2:4, pages 240-245.
Crossref
Crossref
Othman Al Musaimi, Danah Al Shaer, Beatriz de la Torre & Fernando Albericio. (2018) 2017 FDA Peptide Harvest. Pharmaceuticals 11:2, pages 42.
Crossref
Crossref
Thomas Aerden, Koenraad Grisar, Margaux Nys & Constantinus Politis. (2018) Secondary hyperparathyroidism causing increased jaw bone density and mandibular pain: a case report. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 125:3, pages e37-e41.
Crossref
Crossref
Dimce Dzingarski & Kristina Mladenovska. (2017) Pharmacotherapy in chronic kidney disease hyperphosphatemia – effects on vascular calcification and bone health. Macedonian Pharmaceutical Bulletin 63:01, pages 3-24.
Crossref
Crossref